| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |